The involvement of c-Abl and D40 (AF15q14/CASC5) proteins in the regulation of cell proliferation and cancer

Tsitologiya

Volumn 50, Issue 7, 2008, Pages 590-596

  Bogdanov, K V ^a,b   Takimoto, M ^b  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

c Abl; Cell proliferation; D40; Expression; Regulation

Indexed keywords

ABELSON KINASE; AF15Q14 PROTEIN, HUMAN; CARRIER PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ABL; RETINOBLASTOMA PROTEIN;

EID: 51349135008     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Baskaran R., Dahmus M. E., Wang Y. Y. J. 1993. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Nat. Acad. Sci. USA. 90 : 11 167-11171.
2. Belotserkovskaya R., Oh S., Bondarenko V. A., Orphanides G., Studitsky V. M., Reinberg D. 2003. FACT facilitates transcription-dependent nucleosome alteration. Science. 301 : 1090-1093.
3. Biernaux C., Loos M., Sels A., Huez G., Stryckmans P. 1995. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood. 86 : 3118-3122.
4. Brehm A., Kouzarides T. 1999. Retinoblastoma protein meets chromatin. Trends Biochem. Sci. 24 : 142-145.
5. Bogdanov K. V., Urata Y. N., Kuzumaki N., Takimoto M. 2005. Study of human gene D40 that is predominantly expressed in normal testis and cancer. In: Proceedings of COE postdoctoral studies. Hokkaido University. 21 century COE. 28-29.
6. Cam H., Balciunaite E., Biais A., Spektor A., Scarpulla R. C., Young R., Kluger Y., Dynlacht B. D. 2004. A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell. 16 : 399-411.
7. Cheeseman I. M., Niessen S., Anderson S., Hyndman F., Yates J. R., Oegema K., Desai A. 2004. A conserved protein network control assembly of the outer kinetochore and its ability to sustain tension. Genes Develop. 18 : 2255-2268.
8. Chinwalla V., Chien A., Odero M., Neilly M. B., Zeleznik-Le N. J., Rowley J. D. 2003. A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. Oncogene. 22 : 1400-1410.
9. Fainstain E., Einat M., Gokkel E., Marcelle C., Croce C. M., Gale C. M., Canaani E. 1989. Nucleotide sequence analysis of hum an abl and bcr-abl cDNAs. Mol. Cell. Biol. 9 : 1477-1481.
10. Fogerty F. J., Juang J.-L., Petersen J., Clark M. J., Hoffmann F. M., Mosher D. F. 1999. Dominant effects of the bcr-abl oncogene on Drosophila morphogenesis. Oncogene. 18 : 219-232.
11. Gertler F. B., Bennett R. L., Clark M. J., Hoffmann F. M. 1989. Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell. 58 : 103-113.
12. Hayette S., Tigaud I., Vanier A., Martel S., Corbo L., Charrin C., Beillard E., Deleage C., MagaudJ.P., Rimokh R. 2000. AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14). Oncogene. 19 : 4446-4450.
13. Heisterkamp N., Stephenson J. R., Groffen J., Hansen P. F., de Klein A., Bartram C. R., Grosveld G. 1983. Localization of the bcr-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature. 306 : 239-242.
14. Henkemeyer M., Gertler F. B., Goodman W., Hoffman F. M. 1987. The Drosophila Abelson homolog: identification of mutant alleles that have pleiotropic effects late in development. Cell. 51 : 821-828.
15. Irving J. A., O'Brien S., Lennard A. L., Minto L., Lin F., Hall A. G. 2004. Use of denaturing HPLC for detection of mutations in the bcr-abl kinase domain in patients resistant to Imatinib. Clin. Chem. 50 : 1233-1237.
16. lshida S., Huang E., Zuzn H., Spang R., Leone G., West M., Nevin J. R. 2001. Role of E2F in control of both DNA replication and mitotic functions as revealed from DNA microarry analysis. Mol. Cell. Biol. 21 : 4684-4699.
17. Janssen J. W., Ridge S. A., Papadopoulos P., Cotter F., Ludwig W. D., Fonatsch C., Reider H., Ostertag W., Bartram C. R., Wiedemann L. M. 1995. The function of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br. J. Haematol. 90 : 222-224.
18. Jing Y., Song Z., Wang Z., Wang M., Tang W., Hao S., Zeng X. 2005. c-Abl tyrosine kinase regulates c-fos gene expression via phoshorylating RNA polymerase II. Arch. Biochem. Biophys. 437 : 199-204.
19. Kennedy B. K., Barbie D. A., Classon M., Dyson N., Harlow E. 2000. Nuclear organization of DNA replication in primary mammalian cells. Genes Develop. 14 : 2855-2868.
20. Kharbanda S., Pandey P., Morris P. L., Whang Y., Xu Y., Sawant S., Zhu L.-J., Kumar N., Yuan Z.-M., Weichselbaum R., Sawyers C. L., Pandita T. K., Kufe D. 1998. Functional role for c-Abl tyrosine kinase in meiosis I. Oncogene. 16 : 1773-1777.
21. Kipreos E. T., Wang J. Y. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science. 256 : 382-385.
22. Kuefer M. U., Chinwalla V., Zeleznik-Le N. J., Behm F. G., Naeve C. W., Rakestraw K. M., Mukatira S. T., Raimondi S. C., Morris S. W. 2003. Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). Oncogene. 22 : 1418-1424.
23. La Starza R., Trubia M., Testoni N., Ottaviani E., Crescenzi B., Martelli M., Flandrin G., Pellicci P. G., Mecucci C. 2002. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukaemia. Haematologica. 87 : 789-794.
24. Miyamura T., Nishimura J., Yufu Y., Nawata H. 1997. Interaction of bcr-abl with retinoblastoma protein in Philadelphia chromosome-positive cell lines. Int. J. Hematol. 65 : 115-121.
25. Nagano K., Itagaki C., Izumi T., Nunomura K., Soda Y., Tani K., Takahashi N., Takenawa T., Isobe T. 2006. Rb lays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase. Oncogene. 25 : 493-502.
26. NazR. K. 1998. C-Abl proto-oncoprotein is expressed and tyrosine phosphorylated in human sperm cell. Mol. Reprod. Develop. 51 : 210-217.
27. Obuse C., Iwasaki O., Kiyomitsu T., Goshima G., Toyoda Y., Yanagida M. 2004. A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1. Nat. Cell Biol. 6 : 1135-1141.
28. Okuda K., Weisberg E., Gilliland D. G., Griffin J. D. 2001. ARG tyrosine kinase activity is inhibited by STI571. Blood. 97 : 2440-2448.
29. Ponzello C., Wadewitz A. G., Pendergast A. M., Witte O. N., Wolgemuth D. J. 1989. P150 c-Abl is detected in mouse male germ cells by an in kinase assay and is associated with stage-specific phosphoproteins in haploid cells. Oncogene. 4 : 685-690.
30. 2M checkpoints. Genes Develop. 16 : 245-256.
31. Resh M. D. 1994. Myristylation and palmitylation of Src family members: the fats of the matter. Cell. 76 : 411-413.
32. Sasao T., Itoh N., Takano H., Watanabe S., Wei G., Tsukamoto T., Kuzumaki N., Takimoto M. 2004. The protein encoded by cancer/testis gene D40/AF15q14 is localized in spermatocytes, acrosomes of spermatids and ejaculated spermatozoa. Reproduction. 128 : 709-716.
33. Sawyers C. L., McLaughlin J., Goga A., Havlik M., Witte O. 1994. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell. 77 : 121-131.
34. Schindler T., Bornmann W., Pellicena P., Miller W. T., Clarkson B., Kuriyan J. 2000. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science. 289 : 1938-1942.
35. Schwartzherg P. L., Stall A. M., Hardin J. D., Bowdish K. S., Humaran T., Boast S., Harbison M. L., Robertson E. J., Goff S. P. 1991. Mice homozygous for the abl mutation show poor viability and depletion of selected B and T cell populations. Cell. 65 : 1165-1175.
36. Simpson A. J. G., Caballero O. L., Jungbluth A., Chen Y., Old L. J. 2005. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer. 5 : 615-625.
37. Takimoto M., Wei G., Dosaka-Akita H., Mao P., Kondo S., Sakuragi N., Chiba N., Miura T., Itoh N., Sasao T., Koya R. C., Tsukamoto T., Fujimoto S., Katoh H., Kuzumaki N. 2002. Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancer of smoker. Br. J. Cancer. 86 : 1757-1762.
38. Tybulewicz V. L. J., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C. 1991. Neonatal lethality and lymphopenia in mice a homozygous disruption of the c-abl proto-oncogene. Cell. 65 : 1153-1163.
39. Walker L. C., Ganesan T. S., Dhut S., Gibbons B., Lister T. A., Rothbard J., Young B. D. 1987. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature. 329 : 851-853.
40. Wei G., Takimoto M., Yoshida I., Mao P., Koya C. R., Miura T., Kuzumaki N. 1999. Chromosomal assignment of a novel gene D40. Nucl. Acid Symp. Ser. 42 : 71-72.
41. Welch P. J., Wang J. Y. J. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-abl tyrosine kinase in the cell cycle. Cell. 75 : 779-790.
42. Welch P. J., Wang J. Y. J. 1995. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell. Biol. 15 : 5542-5551.
43. Whitaker L. L., Su H., Baskaran R., Knudsen E. S., Wang J. Y. 1998. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol. Cell. Biol. 18 : 4032-4042.
44. Willis S. G., Lange T., Demehri S., Otto S., Crossman L., Niederwieser D., Stoffregen E. P., McWeeney S., Kovacs I., Park B., Druker B. J., Deininger M. W. 2005. High-sensitivity detection of BCR-ABL kinase domain mutations in imatinibnaive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood. 106 : 2128-2137.
45. Witte O. N., Rosenberg N. E., Baltimore D. 1979. A normal cell protein cross-reactive to the Abelson murine leukaemia virus gene product. Nature. 281 : 396-398.
46. Wu C. J., Neuberg D., Chiliemi A., McLaughlin S., Hochberg E. P., Galinsky I., DeAngelo D., Soiffer R. J., Alyea E. P., Capdeville R., Stone R. M., Ritz K. 2002. Quantitative monitoring of BCR/ABL transcript during STI-571 therapy. Leuk. Lymphoma. 43 : 2281-2289.